{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:00:13Z","timestamp":1787580013731,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA093900"],"award-info":[{"award-number":["CA093900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-025-00540-y","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:11:10Z","timestamp":1748869870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating PSA dynamics for predicting androgen deprivation failure with a patient specific prostate cancer model"],"prefix":"10.1038","volume":"11","author":[{"given":"Shengchao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan T.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Ghose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajjai","family":"Alva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trachette","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh Vardhan","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"540_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"540_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James, N. D. et al. The lancet commission on prostate cancer: planning for the surge in cases. Lancet 403, 1683\u20131722 (2024).","journal-title":"Lancet"},{"key":"540_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Prim. 7, 9 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"540_CR4","doi-asserted-by":"crossref","unstructured":"Choi, E., Buie, J., Camacho, J., Sharma, P. & de Riese, W. T. Evolution of androgen deprivation therapy (ADT) and its new emerging modalities in prostate cancer: an update for practicing urologists, clinicians and medical providers. Res. Rep. Urol. 14, 87\u2013108 (2022).","DOI":"10.2147\/RRU.S303215"},{"key":"540_CR5","first-page":"S3","volume":"8","author":"G Chodak","year":"2006","unstructured":"Chodak, G. Prostate cancer: epidemiology, screening, and biomarkers. Rev. Urol. 8, S3 (2006).","journal-title":"Rev. Urol."},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0002-9440(10)64691-3","volume":"158","author":"KR Swanson","year":"2001","unstructured":"Swanson, K. R. et al. A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly. Am. J. Pathol. 158, 2195\u20132199 (2001).","journal-title":"Am. J. Pathol."},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1002\/cso2.1014","volume":"1","author":"JP Barnaby","year":"2021","unstructured":"Barnaby, J. P., Sorribes, I. C. & Jain, H. V. Relating prostate-specific antigen leakage with vascular tumor growth in a mathematical model of prostate cancer response to androgen deprivation. Comput. Syst. Oncol. 1, e1014 (2021).","journal-title":"Comput. Syst. Oncol."},{"key":"540_CR8","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/app10082721","volume":"10","author":"T Phan","year":"2020","unstructured":"Phan, T. et al. Mathematical modeling of prostate cancer and clinical application. Appl. Sci. 10, 2721 (2020).","journal-title":"Appl. Sci."},{"key":"540_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15424-4","volume":"11","author":"R Brady-Nicholls","year":"2020","unstructured":"Brady-Nicholls, R. et al. Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation. Nat. Commun. 11, 1750 (2020).","journal-title":"Nat. Commun."},{"key":"540_CR10","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.3390\/cancers14164033","volume":"14","author":"W Meade","year":"2022","unstructured":"Meade, W. et al. High accuracy indicators of androgen suppression therapy failure for prostate cancer\u2014a modeling study. Cancers 14, 4033 (2022).","journal-title":"Cancers"},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/life13020410","volume":"13","author":"T Phan","year":"2023","unstructured":"Phan, T., Bennett, J. & Patten, T. Practical understanding of cancer model identifiability in clinical applications. Life 13, 410 (2023).","journal-title":"Life"},{"key":"540_CR12","doi-asserted-by":"publisher","first-page":"127rv3","DOI":"10.1126\/scitranslmed.3003180","volume":"4","author":"JR Prensner","year":"2012","unstructured":"Prensner, J. R., Rubin, M. A., Wei, J. T. & Chinnaiyan, A. M. Beyond PSA: the next generation of prostate cancer biomarkers. Sci. Transl. Med. 4, 127rv3\u2013127rv3 (2012).","journal-title":"Sci. Transl. Med."},{"key":"540_CR13","first-page":"207","volume":"9","author":"JL Wright","year":"2007","unstructured":"Wright, J. L. & Lange, P. H. Newer potential biomarkers in prostate cancer. Rev. Urol. 9, 207 (2007).","journal-title":"Rev. Urol."},{"key":"540_CR14","doi-asserted-by":"publisher","first-page":"011002","DOI":"10.1063\/1.3697848","volume":"2","author":"T Portz","year":"2012","unstructured":"Portz, T., Kuang, Y. & James, N. A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy. AIP Adv. 2, 011002 (2012).","journal-title":"AIP Adv."},{"key":"540_CR15","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.3390\/cancers14215319","volume":"14","author":"H Brady-Nichollsand Enderling","year":"2022","unstructured":"Brady-Nichollsand Enderling, H. Range-bounded adaptive therapy in metastatic prostate cancer. Cancers 14, 5319 (2022).","journal-title":"Cancers"},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"e0308173","DOI":"10.1371\/journal.pone.0308173","volume":"19","author":"M Salvioli","year":"2024","unstructured":"Salvioli, M. et al. The effect of tumor composition on the success of adaptive therapy: the case of metastatic castrate-resistant prostate cancer. PLoS ONE 19, e0308173 (2024).","journal-title":"PLoS ONE"},{"key":"540_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.radonc.2008.09.006","volume":"90","author":"CM Zechmann","year":"2009","unstructured":"Zechmann, C. M. et al. Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy\u2014a follow-up study. Radiother. Oncol. 90, 408\u2013412 (2009).","journal-title":"Radiother. Oncol."},{"key":"540_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1158\/1541-7786.MCR-21-1037","volume":"20","author":"X Dong","year":"2022","unstructured":"Dong, X. et al. Modeling androgen deprivation therapy\u2013induced prostate cancer dormancy and its clinical implications. Mol. Cancer Res. 20, 782\u2013793 (2022).","journal-title":"Mol. Cancer Res."},{"key":"540_CR19","first-page":"2135","volume":"24","author":"L Cheng","year":"2004","unstructured":"Cheng, L. et al. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. Anticancer Res. 24, 2135\u20132140 (2004).","journal-title":"Anticancer Res."},{"key":"540_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09431-2","volume":"12","author":"HD Yuk","year":"2022","unstructured":"Yuk, H. D., Byun, S.-S., Hong, S. K. & Lee, H. The tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer. Sci. Rep. 12, 6003 (2022).","journal-title":"Sci. Rep."},{"key":"540_CR21","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.120.242057","volume":"61","author":"R Seifert","year":"2020","unstructured":"Seifert, R. et al. Semiautomatically quantified tumor volume using 68Ga-PSMA-11 PET as a biomarker for survival in patients with advanced prostate cancer. J. Nucl. Med. 61, 1786\u20131792 (2020).","journal-title":"J. Nucl. Med."},{"key":"540_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ncpuro1296","volume":"6","author":"WP Harris","year":"2009","unstructured":"Harris, W. P., Mostaghel, E. A., Nelson, P. S. & Montgomery, B. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat. Clin. Pract. Urol. 6, 76\u201385 (2009).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"540_CR23","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.3390\/cancers14215225","volume":"14","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. A phase 1b adaptive androgen deprivation therapy trial in metastatic castration sensitive prostate cancer. Cancers 14, 5225 (2022).","journal-title":"Cancers"},{"key":"540_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z","volume":"77","author":"TT Wu","year":"1998","unstructured":"Wu, T. T. et al. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID\/bg mice using LNCaP and lineage-derived metastatic sublines. Int. J. Cancer 77, 887\u2013894 (1998).","journal-title":"Int. J. Cancer"},{"key":"540_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mbs.2014.08.008","volume":"256","author":"MC Eisenberg","year":"2014","unstructured":"Eisenberg, M. C. & Hayashi, M. A. Determining identifiable parameter combinations using subset profiling. Math. Biosci. 256, 116\u2013126 (2014).","journal-title":"Math. Biosci."},{"key":"540_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jtbi.2017.07.018","volume":"431","author":"MC Eisenberg","year":"2017","unstructured":"Eisenberg, M. C. & Jain, H. V. A confidence building exercise in data and identifiability: modeling cancer chemotherapy as a case study. J. Theor. Biol. 431, 63\u201378 (2017).","journal-title":"J. Theor. Biol."},{"key":"540_CR27","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/bioinformatics\/btp358","volume":"25","author":"A Raue","year":"2009","unstructured":"Raue, A. et al. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood. Bioinformatics 25, 1923\u20131929 (2009).","journal-title":"Bioinformatics"},{"key":"540_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s12668-017-0465-4","volume":"8","author":"N Gill","year":"2018","unstructured":"Gill, N., Zouwail, S. & Joshi, H. Prostate-specific antigen: a review of assay techniques, variability and their clinical implications. BioNanoScience 8, 707\u2013712 (2018).","journal-title":"BioNanoScience"},{"key":"540_CR29","doi-asserted-by":"publisher","first-page":"1007784","DOI":"10.3389\/fdgth.2022.1007784","volume":"4","author":"EA Stahlberg","year":"2022","unstructured":"Stahlberg, E. A. et al. Exploring approaches for predictive cancer patient digital twins: opportunities for collaboration and innovation. Front. Digit. Health 4, 1007784 (2022).","journal-title":"Front. Digit. Health"},{"key":"540_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach III","year":"2006","unstructured":"Roach III, M. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 65, 965\u2013974 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"540_CR31","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","volume":"26","author":"HI Scher","year":"2008","unstructured":"Scher, H. I. et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate cancer clinical trials working group. J. Clin. Oncol. 26, 1148\u20131159 (2008).","journal-title":"J. Clin. Oncol."},{"key":"540_CR32","unstructured":"Fisher, R. A.The Design of Experiments (Oliver and Boyd, 1935)."},{"key":"540_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00019514-199402020-00006","volume":"2","author":"CH Moore","year":"1994","unstructured":"Moore, C. H. Experimental design in health care. Qual. Manag. Healthc. 2, 13\u201326 (1994).","journal-title":"Qual. Manag. Healthc."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00540-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:11:12Z","timestamp":1748869872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00540-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00540-y","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors S.Z., E.T.K., T.R., J.D., A.G., A.A. and T.J. declare no financial or non-financial competing interests. Author H.V.J. serves as Associate Editor of this journal and had no role in the peer-review process or decision to publish this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}